Buradasınız

Anasayfa » Content

Kronik Böbrek Hastalarında Hemodiyalizin Sol Ventrikül Fonksiyonları Üzerine Olan Etkisinin Ekokardiyografi ile Noninvaziv Değerlendirilmesi

Echocardiographic noninvasive evaluation of the effect of hemodialysis on left ventricle function in patients with chronic renal failure

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 1996

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
To evaluate the effect of hemodialysis on left ventricle function in patients with chronic renal failure, it was studied total 17 patients (11 male and 6 female). From diastolic function parameters peak E wave velocity (PEV), Peak A velocity (PAV), PEV/PAV, E deceleration time (mS) (EDT), and isovolumic relaxation time (IVRT), were found before and after hemodialysis as (72±31, 83±31cm/sec., p<0.001), (65±20, 59±15cm/sec, p<0.009), (1.11±0.3, 1.41±0.39, p<0.01), (158±39,148±38m, p<0.004), (110±28, 94±31mS, p<0.005), respectively. From systolic function parameters Ejection fraction (EF), Cardiac output (CO), Cardiac index (CI), Fractional shortening (FS), Stroke volume (SV), Stroke volume index (SVI), End-diastolic volume (EDV), and End-systolic volume (ESV) were found before and after as (56±8,53±9%, p>0.05), (4.9±2.6 lt/min, 4.6±1.2 lt/min, p>0.05), (3±1.3 lt/min, 3.2±1 lt/min, p>0.05), (31 ±12, 32±12 p>0.05), (56±30ml, 57±14ml, p>0.05), (36±1, 39±11ml/m2, p>0.05), (111 ±36, 102±34ml, p<0.02), (45±14, 43±13ml, p<0.07) respectively. It was concluded that hemodialysis is ineffected on left ventricle systolic function (except EDV) and improved diastolic function. [Journal of Turgut Özal Medical Center 1996;3(2):97-100]
Bookmark/Search this post with
Abstract (Original Language): 
Hemodiyalizin sol ventrikül fonksiyonları üzerine olan etkilerini ekokardiyografi ile noninvaziv olarak incelemek için erkek, 6'sı kadın toplam 17 tane kronik böbrek hastası çalışıldı. Diyastolik fonksiyon parametrelerinden Pik E velosite (PEV), Pik A velosite (PAV), PEV/PAV, E deselerasyon zamanı (EDT) ve İzovolümik relaksasyon zamanı (İVRT) diyaliz öncesi ve sonrası sırasıyla (72±31, 83±31cm/sn, p<0.001), (65+20, 59±15cm/sn, p<0.009), (1.11±0.3,1.41 ±0.39, p<0.01), (158±39,148±38ms, p<0.004), (110±28, 94±31ms, p<0.005) bulundu. Sistolik fonksiyon parametrelerinden Ejeksiyon Fraksiyonu (EF), Kardiyak debi (CO), Kardiyak indeks (CI), Fraksiyonel kısalma (FS), Strok volüm (SV), Strok volüm indeksi(SVİ), End-diyastolik volüm (EDV), End-sistolik volüm(ESV) ise diyaliz öncesi ve sonrası sırasıyla: (56±8, 53±9%, p>0.05), (4.9±2.6, 4.6±1.2 L/dk, p>0.05), (3±1.3, 3.2±1 L/dk/m2, p>0.05), (31 ±12, 32±12, p>0.05), (56±30, 57±14ml, p>0.05), (36±15, 39±11ml/m2, p>0.05), (111 ±36, 102±34ml, p<0.02), (45±14, 43±13ml, p<0.07) olarak bulundu. Sonuç olarak hemodiyalizin diyastolik fonksiyonları iyileştirdiği, sistolik fonksiyonları ise EDV hariç istatiksel olarak etkilemediği bulundu. [Turgut Özal Tıp Merkezi Dergisi 1996;3(2):97-100]
FULL TEXT (PDF): 
PDF icon arastirmax-kronik-bobrek-hastalarinda-hemodiyalizin-sol-ventrikul-fonksiyonlari-uzerine-olan-etkisinin-ekokardiyografi-ile-noninvaziv-degerlendirilmesi.pdf
  • 2
97-100
  • Turkish

REFERENCES

References: 

1. United States Renal Data System 1990: Annual Report Section D18. National Institutes of Diabetes and Digestive and Kidney Disease, Bethesda, MD, August 1990.
2. World Health Statistics Annual 196,1988.
3. Parfrey PS, Harnett JD, Griffiths SM, Gault MH, Barre P. Congestive heart failure in dialysis patients,Arch Intern Med 1988;148:1519-25.
4. Bullock RE, Hassein AA, Simpson I, Ward MK, Hall RJC. Cardiac abnormalities and exercise tolerance in patients receiving renal replacement therapy. BMJ 1984;28:1479-84.
5. Haire HM, Sherrad DH, Scardapane D, Curtis FK, Brunzell JD. Smoking, hypertension and mortality in maintance dialysis population. Cardiovasc Med 1978;3: 63-8.
6. Parfrey PS, Harnett JD, Griffiths SM, Gault MH, Barre PE,
Guttman RD. Low-output left ventricular failure in end-stage
renal disease. Am J Nephrol 1987; 7: 184-91.
7. Parfrey PS, Harnett JD, Griffiths SM, Taylor R, Hand J, King A, Barre PE. The clinical course of left ventricular hypertrophy in dialysis patients. Nephron 1990; 55: 114-20.
8. Harnett JD, Parfrey PS, Griffiths SM, Galt MH, Barre P,
Guttemen RD. Left ventriculer hypertrophy in end-stage renal dissease.Nephron 1988; 48:105-15.
9. Disney A. Fifteenth Report of the Australian and New Zealand Dialysis and Transport Registry (ANZ DATA) Adelaide, South Australia, Australia and New Zealand Dialysis and Transplant Registry, October 1992.
10. Feunmayor AJ, Vasquez CJ, Feunmayor AM, Winterdaal DM, Rodriguez D. Hemodialysis changes the QRS amplitude in the electrocardiogram. Int Journal of Cardiology 1993; 41:141-5.
11. Facchin L, Vescovo G, Levedianos G, Zannini L, Nordio M, Lorenzi S, Caturelli G, Amrosio GB. Left ventricular morphology and diastolic function in uremia: echocardiographic evidence of a spesific cardiomyopathie. Br Heart Journal (England) 1995; 74(2):174-9.

Thank you for copying data from http://www.arastirmax.com